Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07432490 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Primary completion pushed from May 2027 to Jul 2027
    • Start date changed from estimate of May 2026 to May 5, 2026
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).
Trial Details
NCT Number NCT07432490
Lead Sponsor Oregon Health and Science University
Collaborators: Glut1 Deficiency Foundation
Conditions
(from sponsor)		 Glut1 Deficiency, GLUT1DS1
Related terms Glut1 Deficiency Syndrome
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov